ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing
🏛 Food and Drug Administration (FDA)FDA-2026-N-1321
Documents
1
Total comments
67
5 awaiting analysis
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
NoticeApr 30, 2026
ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a HearingOpen · 16 days left💬 67 comments · 5 awaiting analysis